EyeWorld China December 2017

ċʃĀ ތࠕ ʿʭ뻟ćĕƞ ϑȻƥǡĀ ૼΪφԇૼ ŠŖ ح ૼˈɩǡӮͩ ߡװ ɞ ޞ ɪĀΪφԇૼȠȤ뻟चůǡ Ӯ ߂ ŀٌ٩֑Ā׷Ŷɕʭସşŀ ߁ Īܱ ੀ뺯 ĕֻ ތࠕ ƥŶ뻟#'%5 ćȺ ċֶԻũ˨ƈǨĈɃʭචਮ͠ ĝ˩ ܪ ǡӮͩ ߡװ ɞ ޞ ɪ뺯 ʃ ΎşȪą ċʃǎ ૼ ΪφԇૼĀœୖlsư뺯ˈɩǡ Ӯͩ ߡװ ɞ ޞ ɪĀ Ů ɕ뻟ɕʭସşŀ ߁ Īܱ ੀ뻟Ʀ Ůɕ˄ŊĈ뺯ĕƞĪܱ ć /5+%5 ɕħ ੀ뻟ɸ౶ɕħ ੀ뺯 #WTQOQZ Ą ON ዳ઄뻟 ߒ OI ߡ ɞ ޞ ɪ뻟Ǣǁƻ࣪Ѥ뻟ć ߪ ʇĘ̤뺯ύ #WTQNCD ŀм뻟ĕ ĄĂċઐ͒ǘ #'%5 Āֶ ۽ Ȕ ѣ뻟ằđĢDŽԜ ۽ 뺯ǨĈ ތࠕ ਮ ͠ĝćƋ׷ls޿Ĵˈɩ OI #WTQOQZ ߡ ɞ ޞ ɪ ON ǡ Ӯˢˈͩ װ 뺯şȪĀ ތࠕ ̞ಗಈ ٜė ŭ ʃĀԇૼ뺯ć &T %JCPI Ā #5%45s#51# 5[ORQUKWO %QPITGUU Ӳϭ ġ뻟ŴƑĥąಈٜė ŭ ʃĀǡӮ ߡ ɞ ޞ ɪͩ װ ԇૼ̾ ֪뺯qƍć뻟Ȯ ŭ ʃőĀ ċʃǎ뻟āĶĈą ŮΪφɕ뺯 ǡӮ٩֑ȡ ߡ ɞ ޞ ɪͩ װ ɕĀɕʭସşŀ ߁ ħ 뻟Ʀăͩ װ Ā Ůɕħ 뻟rŴζгė뺯&T %JCPI ̛ࣹė뻟ǡӮ ߂ ŀٌ٩ ֑ĀΏƯŢ̆ ތࠕ π˩Ⴌۣ뻟ʼn ȧȥŪ뻟̋ĶĀǂđǟůĄ٩֑ פ ąܱӣɕʭସşŀ ߁ ŘʌĀ ߂ ŀٌȠȱĀȺ̋ĻĩĀƋ׷˄ş ग़뺯q#TCXKPF ތࠕ Ā˓ęƥ̎ ćǘȠŢҽĀĴǎȥŪąęʔĀ Ƌ׷뻟rŴĸ뺯qԨʌ뻟ħąȿīв ߁ ŠŪǕ вॼĀŖę͔뻟ǨĈĀ ɃʭචƋ׷ƶޯćƲċ #'%5 ֶ ԻĝĄƬʇԶѤ͔Ā뻟̞ಗ̹ů ȠǜĀྀঐཾŠ،ᅟ뻟ȠǜĀϥ ࣕѳ҄Šଚ൭ƶʒ뻟rŴƣĸ뺯q ŜǘĕȏʅȂ뻟āΞħĕĄϝǡ ħٜж̰ǡӮ ߂ ŀٌਐв뻟ਯȺ Ą ߡ ɞ ޞ ɪਐвĀŖ˓ĈƺĀ ތࠕ 뺯r 美国的前房莫西沙星选择 ćſŚ뻟ńŊĈ (&# ࣪ѤĻŘ ɕʭ٩֑ȡ̹ůĀ ߂ ŀٌዳ઄Ę ̤뺯qϿĠƋ׷ֶŀˢˈćƋ׷ ة ͩ װ Ȯă ߒ ֑ઈཾĀ ٲ ˌů8K ICOQZ=0QXCT VK U뻟$CUGN뻟5Y KV\GTNCPF? ۀ ɕ઄ӌ։ȿĀ ۽ ˀ뻟r&T %JCPI ĸ뺯ŴȖɥąĂ ձşȪǘ ,QWTPCN QH %CVCTCEV 4GHTCEVKXG 5WTIGT[ Āෞ ۅ 뻟 NJˇॏ௞ąĕƞƶʒŠȗύ뺯q ֶŀκ݉Ňķ뻟ĕƞů़ăđ̹ ů౛̑ĀȪǚů ߡ ɞ ޞ ɪ뻟ĕƞ ۽ ˀ ߒ ᄭ֜ཾ뻟ͩ װ ėɕʭĜĈ ࣕȡ뻟rŴĸ뺯&T %JCPI ̹ů ۽ ӮԜ̑Ā ߡ ɞ ޞ ɪǡӮ٩֑ ȡ̹ů뺯q΀̜ͩ װ ėɕʭĀԜ ̑ ۽ ˀ뻟āĝĜϙůĂċ $ (&# ͩ८Āʌ̞ ۽ Ӯ뻟rŴĸ뺯q Š # ۽ ӮȠȤ뻟 $ ʌ̞ ۽ Ӯκ݉฼ʸƑȀ ߙ ϜĀઠϯ ʳɫ뺯r #5%4 5s#51# 5 [ O R Q U K W O %Q P I T G U U ę Ĝ Ŷ ă ΅ 뻟+ O R T K O K U 2 J C T O C E G W V K E C N U 5 C P &KGIQ ũ˨͎ࣂŠ #TCXKPF ࠕ ތ ̹ůĀ #WTQOQZ Ƞǜ৩ʇ OI ON ĀԜ̑Ā ߡ ɞ ޞ ɪ ዳ઄뺯 &T %JCPI ĸģĈϿĠ ތࠕ ϱŜǡӮǼῇ➹࣡ OI ON ٩֑ȡ̹ůĀȫƽȡŠਐв뺯Ԝ ۽۽ ӮģĻŘ͎ࣂĕƞዳ઄뺯 EWAP ݬ ఠᆪማ 1. Chang DF, et al. Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. , Cataract Refract Surg. 2007;33:1801–5. 2. Chang DF, et al. Antibiotic p r o p h y l a x i s o f p o s t o p e r a t i v e endoph t ha lmi t i s a f t e r c a t a r ac t surgery: Results of the 2014 ASCRS member survey. J Cataract Refract Surg. 2015;41:1300–5. 3. Witkin AJ, et al. Postoperative h emo r r h a g i c o c c l u s i v e r e t i n a l vasculitis: Expanding the clinical spectrum and possible association with vancomycin. Ophthalmol. 2015;122:1438– 51. 4. Witkin AJ, et al. Vancomycin- associated hemorrhagic occlusive r e t i n a l v a s c u l i t i s : C l i n i c a l c h a r a c t e r i s t i c s o f 3 6 e y e s . Ophthalmol. 2017;124:583–595. 5. Haripriya A, et al. Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital. Ophthalmol. 2016;123:302–8. 6. Haripriya A, et al. Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: Analysis of 600,000 surgeries. Ophthalmol. 2017;124:768–775. 7. Javitt JC. Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: Does the preponderance of the evidence mandate a global change in practice? Ophthalmol. 2016;123:226–31. 8. Arshinoff SA, et al. Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis. J Cataract Refract Surg. 2016;42:1730– 41. ৠ٧ͩ뻭&T %JCPI ŠŴĀӇΡ ŊĈǁ࢖ϙॼȱͷ뺯 ԓͷƶК Chang: dceye@earthlink.net 55 EWAP ڹ ดᑇ0JPM 2017年12月